Thirty-year Perspective of the Long-term Survival, CD4 Percentage and Social Achievements of Perinatally HIV-infected Children as a Function of Their Birth Era

Background: Pediatric HIV has evolved from a pre-antiretroviral (ART) era (pre-1989 or pre-ART) to an ART era (1989 to 1996) and to a highly active antiretroviral therapy (HAART) era (post-1996). As we have passed the third decade following these individuals, we thought it useful to review clinical, laboratory and social outcomes. Methods: A retrospective, cross-sectional study of 399 children infected perinatally. They were divided into pre-ART, ART and HAART groups. A Kaplan-Meier plot was constructed. One hundred seventy-nine have been lost to follow-up at an average of 7.6 (0.3–27.6) years. Results: Approximately 40%, 80% and 90% of individuals in the pre-ART, ART and HAART groups have long-term survival. One hundred twenty-one died at an average of 5.1 (0–26.1) years. Pre-ART, ART and HAART groups had mean most recent CD4% values (±SEM) of 16.74 (1.09), 22.97 (0.96) and 33.07 (2.09), respectively (P < 0.001). Pre-ART RNA is limited in that era and present if they survived to another era. In this group, the median RNA values in those who died (311,300, n = 16) was greater than in survivors (19,402, n = 45). Forty-three percent of the individuals in the ART group and 77% of individuals in the HAART group had most recent HIV RNA <400 copies/mL. Eighteen individuals >18 years of age have only a grade school or no education. Fifty-five have graduated high school or received an equivalency diploma. Twenty-three more have completed college. Nadir and recent CD4% of those who did and did not complete high school was equivalent to college graduates. Sixteen survivors (1/2 male) have had 18 uninfected children. Conclusions: This first long-term follow-up study demonstrates remarkable survival and social skills of our patients.

[1]  M. Fowler,et al.  Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival , 2013, Journal of acquired immune deficiency syndromes.

[2]  E. Mills,et al.  Predictive value of CD4 cell count nadir on long-term mortality in HIV-positive patients in Uganda , 2012, HIV/AIDS.

[3]  Susan Morgello,et al.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy , 2011, AIDS.

[4]  M. S. St John,et al.  A descriptive study of HIV-infected long-term surviving children in Barbados--a preliminary report. , 2005, The West Indian medical journal.

[5]  W. Borkowsky,et al.  Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. , 1999, AIDS.

[6]  A. Mocroft,et al.  Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study , 1999, Annals of Internal Medicine.

[7]  D. Picard,et al.  School-related issues among HIV-infected children. , 1997, Pediatrics.

[8]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[9]  W. Borkowsky,et al.  Prognosis of human immunodeficiency virus infection in children and adolescents. , 1989, The Pediatric infectious disease journal.

[10]  W. Borkowsky,et al.  Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. , 1988, The New England journal of medicine.